- Home
- COKE vs BAX Comparison
COKE vs BAX Comparison
Compare COKE & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COKE | BAX |
|---|---|---|
| Founded | 1902 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4B | 13.9B |
| IPO Year | 1994 | 1994 |
Fundamental Metrics
Financial Performance| Metric | COKE | BAX |
|---|---|---|
| Price | $194.88 | $26.63 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $21.00 |
| AVG Volume (30 Days) | 425.7K | ★ 7.6M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.50% | 0.24% |
| EPS Growth | ★ 156.81 | N/A |
| EPS | ★ 1.21 | 0.21 |
| Revenue | $7,228,055,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | N/A | $1.96 |
| Revenue Next Year | N/A | $2.22 |
| P/E Ratio | $162.42 | ★ $125.19 |
| Revenue Growth | 4.76 | ★ 5.72 |
| 52 Week Low | $110.60 | $15.73 |
| 52 Week High | $218.73 | $30.00 |
Technical Indicators
Market Signals| Indicator | COKE | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 61.52 | 56.38 |
| Support Level | $173.57 | $25.75 |
| Resistance Level | $197.15 | $30.00 |
| Average True Range (ATR) | 6.03 | 0.71 |
| MACD | 0.87 | -0.27 |
| Stochastic Oscillator | 98.33 | 28.26 |
Price Performance
Historical ComparisonAbout COKE Coca-Cola Consolidated Inc.
Coca-Cola Consolidated Inc distributes, markets, and manufactures nonalcoholic beverages. It offers a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages, and the Company's principal sparkling beverage is Coca-Cola. Still beverages include energy products and non-carbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices, and sports drinks. The Company has two operating segments: Nonalcoholic Beverages and All Other. Key revenue is generated from Nonalcoholic Beverages.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.